Blog
RSS FeedPosted by Michael Wonder on 30 Jun 2020
Canada federal court dismisses drug makers' plea challenging drug price rules
30 June 2020 - The federal court of Canada on Monday dismissed a plea by drug makers challenging the Canadian ...
Posted by Michael Wonder on 30 Jun 2020
Solutions for the future: a new medicines landscape
30 June 2020 - Medicines New Zealand has just released the 2019/2020 edition of its annual publication New Zealand’s Medicines Landscape ...
Posted by Michael Wonder on 29 Jun 2020
IMC responds to Federal Court decision regarding PMPRB regulatory changes
29 June 2020 - Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada’s ...
Posted by Michael Wonder on 26 May 2020
Medicines New Zealand consulting on a new generation medicines policy
26 May 2020 - The New Zealand Institute of Economic Research have produced a discussion paper for Medicines New Zealand ...
Posted by Michael Wonder on 06 May 2020
Medicines Australia joins forces with 15 health care organisations to highlight continuity of care
6 May 2020 - Right now, more than ever, it is essential that Australians maintain their health. Therefore, Medicines Australia ...
Posted by Michael Wonder on 26 Apr 2020
Medicines Australia reinforces need for continued collaborative commitment to Australia’s medicine supplies
26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ...
Posted by Michael Wonder on 16 Apr 2020
Aid groups ask UK gov to stop pharma 'profiteering' from COVID-19
16 April 2020 - As of this morning – Thursday April 16 – the current recorded case count for COVID-19 ...
Posted by Michael Wonder on 06 Apr 2020
Medicines Australia and the Generic and Biosimilar Medicines Association granted interim authorisation by the ACCC
3 April 2020 - In an important collaborative step, Medicines Australia and the Generic and Biosimilar Medicines Association have today ...
Posted by Michael Wonder on 07 Mar 2020
Is it time to nationalise the pharmaceutical industry?
4 March 2020 - Drug companies fail to take account of the public interest and relentlessly focus on short term returns, ...
Posted by Michael Wonder on 05 Feb 2020
Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
4 February 2020 - As Canada gets set to implement new regulations designed to cut prescription drug spending, the pharmaceutical ...
Posted by Michael Wonder on 22 Jan 2020
Supporting innovative medicines funding in Scotland
21 January 2020 - Scotland receives superb value from the latest medicines and vaccines thanks to robust measures which ensure ...
Posted by Michael Wonder on 17 Jan 2020
Pricing of pharmaceuticals is becoming a major challenge for health systems
13 January 2020 - Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable. ...
Posted by Michael Wonder on 10 Dec 2019
Biotech companies defend prices of one-off gene therapy
9 December 2019 - Latest treatments with price tags as high as $2 million require new financing models. ...
Posted by Michael Wonder on 07 Dec 2019
US pharma companies really do want Britain to pay more for drugs
6 December 2019 - When President Donald Trump arrived in the United Kingdom this week, he landed bang in the ...
Posted by Michael Wonder on 04 Dec 2019
'Cannot be trusted ... causing harm': top medical journal takes on big pharma
4 December 2019 - A leading medical journal is launching a global campaign to separate medicine from big pharma, linking ...